95.019 Syringe Services Programs (SSPs): The Texas Medical Association supports SSPs as an important evidence-based harm reduction strategy among persons who inject drugs (PWIDs) and as an important component of plans to fight against the opioid epidemic. SSPs should be considered a public health intervention aimed at reducing transmission of blood-borne viruses, including HIV and hepatitis C, and that assist PWIDs to obtain treatment and cease using illegally-obtained intravenous drugs. TMA also recognizes that strategies such as SSPs offer a public health benefit by preventing the transmission of infections such as HIV and hepatitis C, resulting in substantial cost savings to government.
TMA also supports: (1) advocating for the elimination of legal barriers to implementing SSPs that are aimed at reducing blood-borne infections and encourages physician education on the evidence of positive health outcomes and cost-effectiveness associated with SSPs; (2) maintaining that any harm reduction strategy among PWIDs should include a recommendation to cease drug use and the provision of effective treatment; (3) encourages the implementation of SSPs at the community level; (4) supports legislation that facilitates SSPs; and (5) will educate its members on the scientific studies relating to SSPs (CM-ID Rep. 4-I-98; reaffirmed CM-ID Rep. 1-A-08; amended CM-ID Rep. 1-A-18).
Last Updated On
August 20, 2018